IBDEI0ER ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6347,2)
 ;;=^5007248
 ;;^UTILITY(U,$J,358.3,6348,0)
 ;;=I50.30^^53^406^2
 ;;^UTILITY(U,$J,358.3,6348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6348,1,3,0)
 ;;=3^Acute Diastolic Heart Failure
 ;;^UTILITY(U,$J,358.3,6348,1,4,0)
 ;;=4^I50.30
 ;;^UTILITY(U,$J,358.3,6348,2)
 ;;=^5007243
 ;;^UTILITY(U,$J,358.3,6349,0)
 ;;=I50.33^^53^406^5
 ;;^UTILITY(U,$J,358.3,6349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6349,1,3,0)
 ;;=3^Acute on Chronic Diastolic Heart Failure
 ;;^UTILITY(U,$J,358.3,6349,1,4,0)
 ;;=4^I50.33
 ;;^UTILITY(U,$J,358.3,6349,2)
 ;;=^5007246
 ;;^UTILITY(U,$J,358.3,6350,0)
 ;;=I50.23^^53^406^7
 ;;^UTILITY(U,$J,358.3,6350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6350,1,3,0)
 ;;=3^Acute on Chronic Systolic Heart Failure
 ;;^UTILITY(U,$J,358.3,6350,1,4,0)
 ;;=4^I50.23
 ;;^UTILITY(U,$J,358.3,6350,2)
 ;;=^5007242
 ;;^UTILITY(U,$J,358.3,6351,0)
 ;;=I50.21^^53^406^4
 ;;^UTILITY(U,$J,358.3,6351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6351,1,3,0)
 ;;=3^Acute Systolic Heart Failure
 ;;^UTILITY(U,$J,358.3,6351,1,4,0)
 ;;=4^I50.21
 ;;^UTILITY(U,$J,358.3,6351,2)
 ;;=^5007240
 ;;^UTILITY(U,$J,358.3,6352,0)
 ;;=I50.42^^53^406^18
 ;;^UTILITY(U,$J,358.3,6352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6352,1,3,0)
 ;;=3^Chronic Combined Systolic & Diastolic Heart Failure
 ;;^UTILITY(U,$J,358.3,6352,1,4,0)
 ;;=4^I50.42
 ;;^UTILITY(U,$J,358.3,6352,2)
 ;;=^5007249
 ;;^UTILITY(U,$J,358.3,6353,0)
 ;;=I50.32^^53^406^19
 ;;^UTILITY(U,$J,358.3,6353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6353,1,3,0)
 ;;=3^Chronic Diastolic Heart Failure
 ;;^UTILITY(U,$J,358.3,6353,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,6353,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,6354,0)
 ;;=I13.0^^53^406^33
 ;;^UTILITY(U,$J,358.3,6354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6354,1,3,0)
 ;;=3^HTN Hrt & CKD w/ Hrt Failure,Stg 1-4 CKD
 ;;^UTILITY(U,$J,358.3,6354,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,6354,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,6355,0)
 ;;=I13.2^^53^406^34
 ;;^UTILITY(U,$J,358.3,6355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6355,1,3,0)
 ;;=3^HTN Hrt & CKD w/ Hrt Failure,Stg 5 or ESRD
 ;;^UTILITY(U,$J,358.3,6355,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,6355,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,6356,0)
 ;;=I11.0^^53^406^45
 ;;^UTILITY(U,$J,358.3,6356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6356,1,3,0)
 ;;=3^Hypertensive Hrt Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,6356,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,6356,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,6357,0)
 ;;=I09.81^^53^406^68
 ;;^UTILITY(U,$J,358.3,6357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6357,1,3,0)
 ;;=3^Rheumatic Hrt Failure
 ;;^UTILITY(U,$J,358.3,6357,1,4,0)
 ;;=4^I09.81
 ;;^UTILITY(U,$J,358.3,6357,2)
 ;;=^5007059
 ;;^UTILITY(U,$J,358.3,6358,0)
 ;;=I50.813^^53^406^6
 ;;^UTILITY(U,$J,358.3,6358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6358,1,3,0)
 ;;=3^Acute on Chronic Right Heart Failure
 ;;^UTILITY(U,$J,358.3,6358,1,4,0)
 ;;=4^I50.813
 ;;^UTILITY(U,$J,358.3,6358,2)
 ;;=^5151387
 ;;^UTILITY(U,$J,358.3,6359,0)
 ;;=I50.811^^53^406^3
 ;;^UTILITY(U,$J,358.3,6359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,6359,1,3,0)
 ;;=3^Acute Right Heart Failure
 ;;^UTILITY(U,$J,358.3,6359,1,4,0)
 ;;=4^I50.811
 ;;^UTILITY(U,$J,358.3,6359,2)
 ;;=^5151385
 ;;^UTILITY(U,$J,358.3,6360,0)
 ;;=I50.82^^53^406^12
